1 / 5

4.8% CAGR Expected To Be Witnessed By Hospital Acquired Infection Control Market

Sales of hospital acquired infections control equipment is expected to be valued at US$ 5,450.6 Mn in 2018 and this is likely to increase to US$ 7,580.8 Mn in 2025, expanding at a CAGR of 4.8% during the study period.

Download Presentation

4.8% CAGR Expected To Be Witnessed By Hospital Acquired Infection Control Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hospital Acquired Infection Control Market Report Id : PMRREP2814 Category : Life Science & Healthcare ©2020 Persistence Market Research, All Rights Reserved

  2. About Persistence Market Research Customized Research Persistence Market Research(Persistence Market Research) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. Persistence Market Research is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Syndicated Research Investment Research Social Media Research Research Capabilities Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Subscription Information For detailed subscription information please contact Website: www.persistencemarketresearch.com For sales queries or new topics email us on: sales@persistencemarketresearch.com

  3. 4.8% Is The CAGR Expected To Be Witnessed, Thereby Bolstering The Hospital Acquired Infection Control Market In 2025 According to a newly published report by Persistence Market Research titled “Hospital Acquired Infections (HAIs) Control Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” sales of hospital acquired infections control equipment is expected to be valued at US$ 5,450.6 Mn in 2018 and this is likely to increase to US$ 7,580.8 Mn in 2025, expanding at a CAGR of 4.8% during the study period. This report tracks the performance of the global hospital acquired infections control market for a period of eight years between 2017 and 2025. A growing prevalence of hospital acquired infections across the globe, rising awareness and demand for new and improved hospital acquired infections treatment modalities, and a rapidly expanding healthcare infrastructure are some of the driving factors of the global hospital acquired infections control market. Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/2814

  4. Global Hospital Acquired Infections Control Market: Restraints • Reported adverse events from failure of endoscope reprocessing to hinder market growth • Excise duty imposed on medical device manufacturers would reduce profit margins • High cost of technology hampering revenue growth of the hospital acquired infections control market • Inadequate reimbursement policies to restrain market growth • Delayed reprocessing and lack of clarity of instruction is a challenge • Stringent rules and regulations to hamper the growth rate of the global market • Low awareness of endoscope reprocessing in developing countries is another restraint • Lack of proper healthcare infrastructure in emerging markets is also restricting revenue growth of the global market Access Full Report @ https://www.persistencemarketresearch.com/checkout/2814

More Related